STM: StoryTelling Medicine Application Using a Virtual Reality Intervention

Sponsor
McMaster University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02687243
Collaborator
(none)
118
1
2
36.4
3.2

Study Details

Study Description

Brief Summary

Preoperative anxiety (PA) affects up to 5 million children in North America each year and is associated with adverse medical, psychological, and behavioral effects. Children who are highly anxious often require more medications during surgical procedures and take longer to recover. While many attempts have been made to reduce PA in children, existing interventions are limited by their expense and time intensive nature. Thus, the current lack of effective and efficient methods of reducing anxiety in children before and after surgery has prompted us to develop and propose to test a new intervention. The investigators have developed a novel,interactive tablet based Virtual Reality program, StoryTelling Medicine (STM), to help reduce anxiety in children undergoing elective surgery, and its associated negative effects.

STM is an age appropriate, customizable program to prepare children for complex surgical procedures by guiding them through the hospital settings. The investigators will examine if STM is effective in reducing PA and its adverse effects in children undergoing surgery. If effective, STM has the potential to improve children's and families' surgical experiences, and reduce health problems in the hospital setting and beyond.

Condition or Disease Intervention/Treatment Phase
  • Device: Interactive Virtual Application
N/A

Detailed Description

Children with PA not only suffer physically and emotionally, but some of them will develop fear of physicians and healthcare providers. These children tend to avoid future medical care and can lead to increased suffering for the child and their family, as well as higher rates of morbidity and health care costs.

There is a paucity of research evaluating the effects of AudioVisual interventions in reducing perioperative anxiety in children undergoing surgery. To date, no one has examined the physiological effects of PA or interventions designed to reduce it.

In the past 2 years, the investigators have conducted 3 pilot studies that have examined the stability of perioperative anxiety in children (n=90) and parents, as well as the feasibility of our recruitment and testing protocol, and to pilot test the interactive tablet-based application. The investigators have established that PA can be reliably and validly measured in children and that the rate of participant recruitment, data collection, website adherence and follow-up protocols for the proposed study are feasible and acceptable. The investigators will now progress to conduct the randomized controlled trial (RCT).

This RCT will be the first to examine the effects of STM in reducing PA and perioperative outcomes in children undergoing elective surgery. Therefore, the investigators will include both behavioral (i.e., observer- and self-rated) and biological measures of stress (i.e., heart rate, salivary cortisol) to further our understanding of the impact of STM on PA.

Unlike existing interventions, the customizable STM program provides a simulated hospital environment that can not only educate, but also increase children's coping abilities to better prepare them for surgery. In addition to reducing children's PA, it can also play an important role in reducing parental anxiety by preparing parents with a knowledge tool to support their child throughout the surgical process.The investigators believe that STM is a promising tool to improve children's health and ease the familial and societal costs of PA in an easy and cost-effective way. Given that many children in other hospitals do not receive adequate preoperative preparation, STM has the potential to provide proper perioperative care for every child in need.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessing the Effects of an Interactive Virtual Reality Intervention in Reducing Preoperative Anxiety in Children Undergoing Elective Surgery: A Randomized Controlled Trial Study Protocol
Actual Study Start Date :
Nov 20, 2019
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interactive Virtual Application

Online application

Device: Interactive Virtual Application
Online application via tablet

No Intervention: Standard of Care

No intervention and Hospital Standard of Care

Outcome Measures

Primary Outcome Measures

  1. Change in Preoperative anxiety [Baseline, Day 1 and One Month]

  2. Change in Heart rate [Baseline and Day 1]

  3. Change in Salivary Cortisol [Baseline and Day 1]

    Saliva cortisol test in ng/dL

Secondary Outcome Measures

  1. Anesthetic induction compliance [Day 1]

  2. Anesthetic Dosage for Sedation [Day 1]

    Anesthetic agent and dosage used

  3. Delirium [Day 1]

    Nursing notes

  4. Length of Stay [Day 1]

    Hospital records

  5. Analgesic Usage [Day 1]

    Medication Chart

  6. Post-Hospital Behaviour [One month]

    Using Post-Hospital Behaviour Questionnaire (PHBQ)

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children between the ages of 8-13 who are scheduled to receive any outpatient surgery (i.e. tonsillectomy, herniorrhaphy)
Exclusion Criteria:
  • Children with chronic illnesses (e.g., cancer), known neurodevelopmental disorders, or who are on psychotropic medications prior to randomization will be excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 McMaster Children's Hospital Hamilton Ontario Canada L8S 4K1

Sponsors and Collaborators

  • McMaster University

Investigators

  • Principal Investigator: Desigen Reddy, MD, Hamilton Health Sciences Corporation

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
McMaster University
ClinicalTrials.gov Identifier:
NCT02687243
Other Study ID Numbers:
  • 2015-1220
First Posted:
Feb 22, 2016
Last Update Posted:
Feb 24, 2021
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by McMaster University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2021